Literature DB >> 19647741

Phosphorylation of more than one site is required for tight interaction of human tau protein with 14-3-3zeta.

Nikolai N Sluchanko1, Alim S Seit-Nebi, Nikolai B Gusev.   

Abstract

Serine residues phosphorylated by protein kinase A (PKA) in the shortest isoform of human tau protein (tau3) were sequentially replaced by alanine and interaction of phosphorylated tau3 and its mutants with 14-3-3 was investigated. Mutation S156A slightly decreased interaction of phosphorylated tau3 with 14-3-3. Double mutations S156A/S267A and especially S156A/S235A, strongly inhibited interaction of phosphorylated tau3 with 14-3-3. Thus, two sites located in the Pro-rich region and in the pseudo repeats of tau3 are involved in phosphorylation-dependent interaction of tau3 with 14-3-3. The state of tau3 phosphorylation affects the mode of 14-3-3 binding and by this means might modify tau filament formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647741     DOI: 10.1016/j.febslet.2009.07.043

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

2.  Identification of the Al-binding proteins that account for aluminum neurotoxicity and transport in vivo.

Authors:  Dai Cheng; Xiaomei Wang; Yu Xi; Jiankang Cao; Weibo Jiang
Journal:  Toxicol Res (Camb)       Date:  2017-12-01       Impact factor: 3.524

3.  Quantitative mapping of microtubule-associated protein 2c (MAP2c) phosphorylation and regulatory protein 14-3-3ζ-binding sites reveals key differences between MAP2c and its homolog Tau.

Authors:  Séverine Jansen; Kateřina Melková; Zuzana Trošanová; Kateřina Hanáková; Milan Zachrdla; Jiří Nováček; Erik Župa; Zbyněk Zdráhal; Jozef Hritz; Lukáš Žídek
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

Review 4.  Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

Authors:  Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 5.  Tau and tauopathies.

Authors:  Gloria Lee; Chad J Leugers
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

6.  Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.

Authors:  Shelby Meier; Michelle Bell; Danielle N Lyons; Alexandria Ingram; Jing Chen; John C Gensel; Haining Zhu; Peter T Nelson; Jose F Abisambra
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  Familial amyloid polyneuropathy in Portugal: New genes modulating age-at-onset.

Authors:  Diana Santos; Teresa Coelho; Miguel Alves-Ferreira; Jorge Sequeiros; Denisa Mendonça; Isabel Alonso; Carolina Lemos; Alda Sousa
Journal:  Ann Clin Transl Neurol       Date:  2016-12-20       Impact factor: 4.511

8.  Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction.

Authors:  Kristina V Tugaeva; Philipp O Tsvetkov; Nikolai N Sluchanko
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

9.  Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy.

Authors:  Niko Hensel; Federica Cieri; Pamela Santonicola; Ines Tapken; Tobias Schüning; Michela Taiana; Elisa Pagliari; Antonia Joseph; Silke Fischer; Natascha Heidrich; Hella Brinkmann; Sabrina Kubinski; Anke K Bergmann; Manuela F Richter; Klaus Jung; Stefania Corti; Elia Di Schiavi; Peter Claus
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

Review 10.  Derailed intraneuronal signalling drives pathogenesis in sporadic and familial Alzheimer's disease.

Authors:  Tom Van Dooren; Katrien Princen; Koen De Witte; Gerard Griffioen
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.